San Diego, you’re not going to want to miss this giveaway 🫶 We are giving away a new Padres City Connect jersey just for you! Repost and reply for your chance to win!

Marshall Hawks: Venture Debt Deals - Funding Growth with Less Dilution open.substack.com/pub/derekr…

If you are curious about venture debt or financing growth you might like this recent interview I hosted with Marshall Hawks Marshall Hawks: Venture Debt Deals - Funding Growth with Less Dilution open.substack.com/pub/derekr…

L.O.T.W. #141 - Nerdy Gets Smart with New Growth Capital Term Loan open.substack.com/pub/derekr…

Just created a complete analysis of AI infrastructure opportunities covering chip manufacturers, power companies and system integrators. I shared this analysis with my 20,000 students. For 24 hours, it's yours for FREE. Like, RT & Comment "AI" and I'll DM it to you.

L.O.T.W. #140 - TG-17 (Bond) Recently Filed S-1 Sheds Light on Existing Venture Term Loan open.substack.com/pub/derekr…

I'm seeing this so often, it's time to speak out: the dreaded #startup "DOWN round" financing where founder equity is wiped out. (You'll want to RT this.) How does a founder avoid this from its insider VCs? Here's the founder's checkmate move: "pay to play". find an investor (outsider is best, but any investor will do, even the founder herself) and put forth a term sheet that funds the company to a new milestone/inflection point... doesn't need to be huge, even 3 months runway is enough. force every investor (including the vulture capitalist down rounders) to participate or get wiped out in a forced conversion to common (often a reverse 10:1). close round. Ask your lawyers, find an investor ally, and execute. Don't get down rounded - that's for amateurs. RT please to help founders in 2023.

To my friends in SF this week for #JPM23 #BiotechShowcase2023 good luck, stay safe, and make it rain!

C’mon. Everyone knows VT is actually Southern Quebec.

Thanks @BMWPDS for a great M School experience. As a longtime owner (first introduced to the brand in ‘93 via a ‘73 2002) and former intern at BMWNA (Motorcyle Group ‘98) the experience meant a lot. Great instructors and fantastic fun with the M2, M4, and M5. #20BMWPC

Q2/3 2018 - Best 6-Month VC-backed Biotech IPO Period Ever? Q2: 20 IPOs, Median Pre$: $340M; 10/20 Pre-Clin or Phase I; Median TTE from Series A: 2.5 years Q3: 15 IPOs, Median Pre$: $295M; 5/15 Pre-Clin or Phase I; Median TTE from Series A: 3.5 years Proof will b in performance!

Learn how to determine the right funding source for your company.

Venture-Backed Biopharma IPO Update 2018: 38 Median IPO Pre: $325M Median Raised: $100M Time from A to IPO: median 3.0 yrs. 7 deals < 2 yrs Pre-Clin/Phase I IPOs: 16 of 38 IPOs with pvt inv. by Top 15 Crossovers: 27 of 38 Top by Lead: 11 Platform, 9 Onc, 4 Anti-Inf., 4 Orph/Rare

See how EpiBone is changing the future of bone reconstruction with support from J.P Morgan's Life Sciences team. #JPMHC18 cards.twitter.com/cards/qcjz…

We're proud to present the Fiercest Women in Life Sciences for 2017 fiercepharma.com/pharma/2017…

It took avg of 4.1 years in drug discovery in 1998. It takes 4.1 years now, nearly 20 years later (accdg to KMR). I'm both frustrated and puzzled by this - where's the "big impact" of massive increases in computational power on shortening drug discovery cycle times?

On the edge of our seats for another night of #NittoATPFinals in London. $JPM is proud to be a sponsor: bit.ly/JPM_ATPFinals

We're doomed. x.com/rainmaker1973/status/9…

BREAKING: Equifax reports cybersecurity incident potentially impacting approx. 143M US consumers cnbc.com/2017/09/07/credit-r…